Company news

Lifeward Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Lifeward Announces CEO Transition

February 19, 2025

Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany

February 4, 2025

Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025

February 3, 2025

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

January 12, 2025

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

January 12, 2025

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

January 6, 2025

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

December 26, 2024

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

November 18, 2024

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

November 11, 2024

Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors

November 6, 2024

Lifeward to Report Third Quarter Financial Results on November 12, 2024

November 4, 2024

Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies

November 3, 2024

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

October 23, 2024

Lifeward Launches Direct Sales of AlterG Product Line in Germany

September 23, 2024

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

September 11, 2024

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

September 9, 2024

Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

September 4, 2024

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

September 3, 2024

Lifeward Reports Second Quarter 2024 Financial Results

August 14, 2024

Lifeward to Report Second Quarter Financial Results on August 15, 2024

August 7, 2024

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

July 1, 2024

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

June 25, 2024

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

June 3, 2024

Lifeward Reports First Quarter 2024 Financial Results

May 14, 2024

Lifeward to Report First Quarter Financial Results on May 15, 2024

May 6, 2024

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

April 18, 2024

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

April 11, 2024

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

March 31, 2024

VA STAND Act introduced in the United States Senate

March 21, 2024

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

March 7, 2024

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may...

February 29, 2024

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

February 26, 2024

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

February 19, 2024

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

January 28, 2024

ReWalk Robotics Expands Direct Sales Coverage to Canada

January 11, 2024

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

January 10, 2024

First ReWalk Personal Exoskeleton Claim Paid by Medicare

January 4, 2024

ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities

January 3, 2024

ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting

November 29, 2023

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

November 27, 2023

ReWalk Robotics Reports Third Quarter 2023 Financial Results

November 13, 2023

New Bill Facilitates Veteran Access to Powered Exoskeletons

November 9, 2023

ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023

November 6, 2023

ReWalk Robotics to Discuss Medicare’s Preliminary Payment Determination for ReWalk Personal Exoskeleton

November 6, 2023

In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton

November 5, 2023

Medicare Coverage Solidified for ReWalk Personal Exoskeleton

November 1, 2023

ReWalk Robotics Exhibits at the GITEX GLOBAL Intelligent Connectivity / AI Pavilion

October 17, 2023

ReWalk Robotics Offers Thanks to Former Director for His Loyal Service and Valuable Contributions

September 19, 2023

ReWalk Robotics Ltd. to Present Virtually at H.C. Wainwright 25th Annual Global Investment Conference

September 5, 2023

ReWalk Robotics Announces Additional Change to Board of Directors

September 4, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 10 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.